Ori Biotech Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
73
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$101M
- Investors
-
13
Ori Biotech General Information
Description
Developer of cell and gene therapy (CGT) technology designed for process discovery, translation, and scalable commercialization of cells and genes. The company's manufacturing platform automates CGT manufacturing to increase throughput, improve quality, and decrease costs by combining proprietary hardware, software, data, and analytics, enabling therapeutics developers to develop and bring products to market at a commercial scale and patients to access personalized and life-saving treatments.
Contact Information
Website
www.oribiotech.comCorporate Office
- 5-10 Brandon Road
- London N7 9AA
- England, United Kingdom
Corporate Office
- 5-10 Brandon Road
- London N7 9AA
- England, United Kingdom
Ori Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B) | 07-Jan-2022 | $101M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series A) | 24-Aug-2020 | Completed | Generating Revenue | |||
| 4. Grant | 01-May-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 22-Aug-2019 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 04-May-2018 | $270K | $456K | Completed | Generating Revenue | |
| 1. Angel (individual) | 29-Nov-2016 | $187K | $187K | Completed | Generating Revenue |
Ori Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Ordinary | ||||||||
| Series A | ||||||||
| Ordinary | ||||||||
| Seed Preferred | ||||||||
| Seed Ordinary | ||||||||
| Seed Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 134,584 | $0.000134 | $0.6 | $0.6 | 1x | $0.6 | 0.42% | |
| Ordinary | 60,900 | $0.000134 | $0.6 | $0.6 | 1x | $0.6 | 0.19% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ori Biotech Comparisons
Industry
Financing
Details
Ori Biotech Competitors (8)
One of Ori Biotech’s 8 competitors is Cellares, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cellares | Venture Capital-Backed | South San Francisco, CA | ||||
| Multiply Labs | Venture Capital-Backed | San Francisco, CA | ||||
| TrakCel | Venture Capital-Backed | Cardiff, United Kingdom | ||||
| Therapure Biopharma | Formerly PE-Backed | Mississauga, Canada | ||||
| Celonic | Corporate Backed or Acquired | Basel, Switzerland |
Ori Biotech Patents
Ori Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202509075-D0 | A method | Pending | 09-Jun-2025 | ||
| GB-202509076-D0 | Method of mixing particles in a liquid medium | Pending | 09-Jun-2025 | ||
| GB-202505841-D0 | A connector | Pending | 17-Apr-2025 | ||
| GB-202505842-D0 | A connector | Pending | 17-Apr-2025 | ||
| WO-2026220158-A1 | A connector | Pending | 17-Apr-2025 | A61M39/105 |
Ori Biotech Signals
Ori Biotech Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Chimera Capital | PE/Buyout | Minority | ||
| Angel (individual) | Minority | |||
| Novalis LifeSciences | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Ori Biotech FAQs
-
When was Ori Biotech founded?
Ori Biotech was founded in 2015.
-
Where is Ori Biotech headquartered?
Ori Biotech is headquartered in London, United Kingdom.
-
What is the size of Ori Biotech?
Ori Biotech has 73 total employees.
-
What industry is Ori Biotech in?
Ori Biotech’s primary industry is Other Devices and Supplies.
-
Is Ori Biotech a private or public company?
Ori Biotech is a Private company.
-
What is the current valuation of Ori Biotech?
The current valuation of Ori Biotech is .
-
What is Ori Biotech’s current revenue?
The current revenue for Ori Biotech is .
-
How much funding has Ori Biotech raised over time?
Ori Biotech has raised $140M.
-
Who are Ori Biotech’s investors?
, Chimera Capital, , Novalis LifeSciences, and are 5 of 13 investors who have invested in Ori Biotech.
-
Who are Ori Biotech’s competitors?
Cellares, Multiply Labs, TrakCel, Therapure Biopharma, and Celonic are some of the 8 competitors of Ori Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process